Abstract
Objectives: To compare the efficacy & safety of urinary Human Menopausal Gonadotropin (u-hMG; Menodac™; Zydus Biogen, India) versus Recombinant Human Follicle Stimulating Hormone (rec-FSH; Recagon™; Organon, India) for the induction of superovulation in women undergoing Assisted Reproductive Techniques.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
